Which is the better beaten-up buy, Bubs or A2 Milk shares?

A decline in the Chinese infant formula market has hurt both of these companies.
The post Which is the better beaten-up buy, Bubs or A2 Milk shares? appeared first on The Motley Fool Australia. –

The A2 Milk Company Ltd (ASX: A2M) share price and the Bubs Australia Ltd (ASX: BUB) share price have both suffered in recent times.

Over the last six months, the Bubs share price is down around 33%. The A2 Milk share price is down a similar level, around 35%.

From the peak in July 2020, A2 Milk shares are down around 80%. Looking at Bubs, it has declined more than 60% since July 2020.

Both businesses have seen similar falls, but which one is the better buy?

What’s the problem?

China is a key market for infant formula from both of these businesses. The country had a population of around 1.4 billion in 2021, so that’s a very large potential market of families that may want to buy infant nutrition.

A2 Milk blamed the decline on the prolonged impact of COVID-19 and a rapidly changing infant formula market. In FY21, it said that over the year the Chinese market growth reduced significantly from “globally high rates to be flat, and cross-border trade has been disrupted significantly which has had a profound impact on the company’s results”.

A2 Milk shares faltered as sales through the daigou/reseller and e-commerce channels suffered.

In FY21, the company saw revenue fall 30.3% to $1.21 billion and net profit after tax (NPAT) sank 79.1% to $80.7 million. A2 Milk took action to address excess inventory. It said this was reducing channel inventory, improving product freshness, and market pricing.

Bubs also saw a significant drop in daigou sales in FY21, with gross revenue dropping 24% to $46.8 million. It also suffered from an inventory write-down to the tune of $12.6 million.

Growth returning?

While FY21 saw a lot of disruption, things are improving.

A2 Milk is expecting to deliver revenue growth in FY22. The HY22 revenue was slightly down by 2.5% to $660.5 million. The overall Chinese infant formula market declined by 3.3% in value during the first half due to the impact of a lower birth rate.

A2 Milk is expecting the FY22 second-half revenue to be much more than that in the FY21 second half.

The latest update we’ve seen from Bubs is the FY22 third quarter. Gross revenue was up 49% to $17.6 million, the third consecutive quarter of growth on the prior year. Domestic retail infant formula sales rose 108% year on year. Total Chinese sales were up 8%. Excluding China, international gross revenue was up 153%, with international sales of Bubs-branded products growing by 63%.


Bubs is not yet profitable, while A2 Milk is. Profitability can be a help for the A2 Milk share price.

A2 Milk made an NPAT of $56.1 million in the first half of FY22, though this was down 53.3%.

Despite the revenue growth expectations, A2 Milk isn’t expecting higher earnings as it “significantly” invests in the market and other activities related to its growth strategy.

Which one is better?

It may be that A2 Milk has a stronger brand, for now at least.

But Bubs is growing quickly. It’s growing strongly internationally, in Asian countries outside of China.

The broker Citi currently rates Bubs as a buy, with a price target of 59 cents. That implies a possible upside of around 57% on its current price of 37.5 cents. It noted the Chinese lockdowns could slow growth in the short term. It also noted Bubs’ new A2 beta-casein protein infant formula range, with the corporate daigou partner Willis Trading putting in an order valued at $32.9 million.

Citi rates A2 Milk shares as a sell, with a price target of $4.80. Citi thinks that A2 Milk could suffer from the lockdowns.

In my opinion, Bubs has managed to turn things around over the last several months. Its growth is now looking stronger than A2 Milk, it’s growing its product range and it’s setting the scene for good growth internationally by expanding its footprint in the US. For those reasons, I’d pick Bubs of the two. But share market volatility could remain elevated for a while.

The post Which is the better beaten-up buy, Bubs or A2 Milk shares? appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

More reading

Bubs share price sinks 29% in a month. Top broker tips 60% upside
Why A2 Milk, Imugene, Liontown, and Magellan shares are tumbling lower
A2 Milk share price sinks to multi-year low following broker downgrade
What’s the outlook for the A2 Milk share price in May?
The A2 Milk share price plunged 15% in April. What went wrong?

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk and BUBS AUST FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US & HK* Trades. Click Here!